RosinaH's blog

When it comes to managing nausea, healthcare providers often rely on anti-emetic medications to alleviate symptoms and improve patient comfort. Nausea can arise from various causes, including chemotherapy, post-operative recovery, motion sickness, or gastrointestinal disorders. The selection of an appropriate anti-emetic drug depends on factors such as the underlying cause of nausea, patient preferences, potential side effects, and the specific pharmacological properties of the medication.

https://www.medicalnewstoday.com/articles/320384

Here's an overview of some commonly used anti-emetic drugs:

1. 5-HT3 Receptor Antagonists

Mechanism of Action: These drugs block serotonin (5-HT3) receptors in the chemoreceptor trigger zone (CTZ) and gastrointestinal tract, thereby reducing nausea and vomiting signals to the brain.

Examples:

• Ondansetron (Zofran): ondansetron odt is a widely used 5-HT3 receptor antagonist. It's effective for preventing nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery. It's available in oral, intravenous (IV), and orally disintegrating tablet forms, making it versatile for different patient needs.

• Granisetron (Kytril), Palonosetron (Aloxi): These are other examples of 5-HT3 receptor antagonists with similar mechanisms of action. They are often used in chemotherapy-induced nausea and vomiting (CINV), particularly for patients undergoing highly emetogenic chemotherapy regimens.

Administration: Typically administered orally or via IV. Ondansetron, for instance, has a rapid onset of action when given IV, making it suitable for acute settings like chemotherapy infusion centers.

Side Effects: Common side effects include headache, constipation, and fatigue. In some cases, there may be QT interval prolongation, so caution is advised in patients with pre-existing cardiac conditions.

2. Dopamine D2 Receptor Antagonists

Mechanism of Action: These drugs block dopamine receptors in the CTZ and are effective against nausea and vomiting.

Examples:

• Metoclopramide (Reglan): Metoclopramide is a dopamine D2 receptor antagonist that also has prokinetic properties, enhancing gastric emptying. It's used for nausea and vomiting associated with chemotherapy, post-operative recovery, and gastroparesis. Metoclopramide can be administered orally, intravenously, or intramuscularly.

Administration: Available in multiple forms for flexible administration. IV metoclopramide has a rapid onset of action, making it suitable for acute settings.

Side Effects: Side effects may include restlessness, drowsiness, and extrapyramidal symptoms (e.g., dystonia, tardive dyskinesia). Long-term use can rarely lead to tardive dyskinesia, so it's generally recommended for short-term use.

3. Corticosteroids

Mechanism of Action: Corticosteroids have anti-inflammatory effects and can help reduce nausea, particularly when used in combination with other anti-emetics.

Examples:

• Dexamethasone: Dexamethasone is commonly used in combination therapy for CINV. It reduces inflammation and enhances the effectiveness of other anti-emetic medications.

Administration: Typically administered orally or via IV. Dexamethasone is often given as a single dose before chemotherapy to prevent acute CINV.

Side Effects: Side effects can include increased appetite, insomnia, and fluid retention. Long-term use can lead to adrenal suppression, so it's used cautiously and for short durations in anti-emetic therapy.

4. NK1 Receptor Antagonists

Mechanism of Action: These drugs block substance P, a neurotransmitter involved in nausea and vomiting pathways.

Examples:

• Aprepitant (Emend), Fosaprepitant (Ivemend): Aprepitant and its IV prodrug fosaprepitant are NK1 receptor antagonists used in combination with 5-HT3 antagonists and corticosteroids for CINV prevention. They are particularly effective against delayed nausea and vomiting post-chemotherapy.

Administration: Aprepitant is administered orally, while fosaprepitant is administered intravenously. They are typically given in combination with other anti-emetics in the days surrounding chemotherapy treatment.

Side Effects: Common side effects include fatigue, dizziness, and constipation. Aprepitant can interact with certain medications metabolized by CYP3A4, so dose adjustments may be necessary.

5. Antihistamines (H1 Receptor Antagonists)

Mechanism of Action: These drugs block histamine receptors in the vestibular system and CTZ, reducing nausea and vomiting.

Examples:

• Dimenhydrinate (Dramamine), Meclizine (Antivert): These antihistamines are commonly used for motion sickness and nausea associated with vestibular disorders. They are also used in combination therapy for nausea management.

Administration: Administered orally. They are effective for preventing motion sickness and are available over-the-counter.

Side Effects: Side effects may include drowsiness, dry mouth, and blurred vision. They are generally well-tolerated but can cause sedation, so caution is advised during activities requiring alertness. Extra information : https://iie.edu.au/wp-content/uploads/fsqm-files/123.pdf